These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20015281)

  • 21. Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades.
    Amer AA; Gao XH
    Int J Dermatol; 2016 Jun; 55(6):608-14. PubMed ID: 26749040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics in 113 Turkish vitiligo patients.
    Arýcan O; Koç K; Ersoy L
    Acta Dermatovenerol Alp Pannonica Adriat; 2008 Sep; 17(3):129-32. PubMed ID: 18853076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The psychosocial impact of vitiligo in Indian patients.
    Pahwa P; Mehta M; Khaitan BK; Sharma VK; Ramam M
    Indian J Dermatol Venereol Leprol; 2013; 79(5):679-85. PubMed ID: 23974584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic interventions to lessen the psychosocial effect of vitiligo in children: A review.
    Cadmus SD; Lundgren AD; Ahmed AM
    Pediatr Dermatol; 2018 Jul; 35(4):441-447. PubMed ID: 29766546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond Traditional Treatment: The Importance of Psychosocial Therapy in Vitiligo.
    Rzepecki AK; McLellan BN; Elbuluk N
    J Drugs Dermatol; 2018 Jun; 17(6):688-691. PubMed ID: 29879259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life and emotional state in vitiligo in an Estonian sample: comparison with psoriasis and healthy controls.
    Karelson M; Silm H; Kingo K
    Acta Derm Venereol; 2013 Jul; 93(4):446-50. PubMed ID: 23306792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychologic effects of vitiligo: a critical incident analysis.
    Kent G; Al'Abadie M
    J Am Acad Dermatol; 1996 Dec; 35(6):895-8. PubMed ID: 8959947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. To what extent is quality of life impaired in vitiligo? A multicenter study on Italian patients using the dermatology life quality index.
    Ingordo V; Cazzaniga S; Medri M; Raone B; Digiuseppe MD; Musumeci ML; Romano I; Fai D; Pellegrino M; Pezzarossa E; Di Lernia V; Peccerillo F; Battarra VC; Sirna R; Patrizi A; Naldi L
    Dermatology; 2014; 229(3):240-7. PubMed ID: 25358871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life of adult vitiligo patients using camouflage: A survey in a Chinese vitiligo community.
    Chen D; Tuan H; Zhou EY; Liu D; Zhao Y
    PLoS One; 2019; 14(1):e0210581. PubMed ID: 30677057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pattern of vitiligo.
    Habib A; Raza N
    J Coll Physicians Surg Pak; 2012 Jan; 22(1):61-2. PubMed ID: 22237197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics.
    Nicolaidou E; Antoniou C; Miniati A; Lagogianni E; Matekovits A; Stratigos A; Katsambas A
    J Am Acad Dermatol; 2012 Jun; 66(6):954-8. PubMed ID: 21982634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Life quality assessment among patients with vitiligo: comparison of married and single patients in Iran.
    Dolatshahi M; Ghazi P; Feizy V; Hemami MR
    Indian J Dermatol Venereol Leprol; 2008; 74(6):700. PubMed ID: 19177700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of factors associated with health-related quality of life and psychological distress in vitiligo.
    Bonotis K; Pantelis K; Karaoulanis S; Katsimaglis C; Papaliaga M; Zafiriou E; Tsogas P
    J Dtsch Dermatol Ges; 2016 Jan; 14(1):45-9. PubMed ID: 26713637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment and Comparison of Quality of Life in Patients with Melasma and Vitiligo.
    Amatya B; Pokhrel DB
    Kathmandu Univ Med J (KUMJ); 2019; 17(66):114-118. PubMed ID: 32632057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Vitiligo Impact Patient Scale (VIPs): Development and Validation of a Vitiligo Burden Assessment Tool.
    Salzes C; Abadie S; Seneschal J; Whitton M; Meurant JM; Jouary T; Ballanger F; Boralevi F; Taieb A; Taieb C; Ezzedine K
    J Invest Dermatol; 2016 Jan; 136(1):52-8. PubMed ID: 26763423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What patients with vitiligo believe about their condition.
    Firooz A; Bouzari N; Fallah N; Ghazisaidi B; Firoozabadi MR; Dowlati Y
    Int J Dermatol; 2004 Nov; 43(11):811-4. PubMed ID: 15533062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality-of-life issues in vitiligo.
    Bhandarkar SS; Kundu RV
    Dermatol Clin; 2012 Apr; 30(2):255-68, viii. PubMed ID: 22284140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitiligo prevalence study in Shaanxi Province, China.
    Lu T; Gao T; Wang A; Jin Y; Li Q; Li C
    Int J Dermatol; 2007 Jan; 46(1):47-51. PubMed ID: 17214719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life in patients with vitiligo.
    Parsad D; Dogra S; Kanwar AJ
    Health Qual Life Outcomes; 2003 Oct; 1():58. PubMed ID: 14613564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the psychosocial impact of a Social Interaction Skills Training (SIST) workshop for patients with vitiligo: A pilot study.
    Tan A; Schuster LM; Robbins MA; Holavanahalli R; Pandya AG
    J Am Acad Dermatol; 2020 Aug; 83(2):645-647. PubMed ID: 31765678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.